Ex Parte Falta et al - Page 5

           Appeal 2006-1708                                                                         
           Application 10/186,253                                                                   

        1        Objective evidence of nonobviousness including commercial success must             
        2  be commensurate in scope with the claims.  In re Tiffin, 448 F.2d 791, 792, 171          
        3  USPQ 294, 294 (CCPA 1971).  In order to be commensurate in scope with the                
        4  claims, the commercial success must be due to claimed features, and not due to           
        5  unclaimed features.  Joy Technologies Inc. v. Manbeck, 751 F.Supp. 225, 229, 17          
        6  USPQ2d 1257, 1260 (D.D.C. 1990), aff’d, 959 F.2d 226, 228, 22 USPQ2d 1153,               
        7  1156 (Fed. Cir. 1992).                                                                   
        8        Our reviewing court has noted in the past that evidence related solely to the      
        9  number of units sold provides a very weak showing of commercial success, if any.         
       10  See In re Huang, 100 F.3d 135, 139-40, 40 USPQ2d 1685, 1689 (Fed. Cir. 1996);            
       11  Cable Elec. Prods. v. Genmark, Inc., 770 F.2d 1015, 1026-27, 226 USPQ 881, 888           
       12  (Fed. Cir. 1985) (finding that sales of 5 million units represent a minimal showing      
       13  of commercial success because "[w]ithout further economic evidence                       
       14  . . . it would be improper to infer that the reported sales represent a substantial      
       15  share of any definable market"); see also Baxter Travenol Labs., 952 F.2d at 392,        
       16  21 USPQ2d at 1285 (Fed. Cir. 1991) ("[I]nformation solely on numbers of units            
       17  sold is insufficient to establish commercial success."); Kansas Jack, Inc. v. Kuhn,      
       18  719 F.2d 1144, 1151, 219 USPQ 857, 861 (Fed. Cir. 1983) (determination of                
       19  obviousness not erroneous where evidence of commercial success consisted solely          
       20  of number of units sold and where no evidence of nexus).                                 
       21        A nexus is required between the sales and the merits of the claimed                
       22  invention.  In ex parte proceedings before the Patent and Trademark Office, an           
       23  applicant must show that the claimed features were responsible for the commercial        
       24  success of an article if the evidence of nonobviousness is to be accorded substantial    
       25  weight.  Merely showing that there was commercial success of an article which            
       26  embodied the invention is not sufficient.  See Ex parte Remark, 15 USPQ2d 1498,          

                                                 5                                                  


Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next

Last modified: September 9, 2013